rosoxacin

Known as: Rosoxacino, Rosoxacine, Rosoxacinum 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Rosiglitazone (RO), a second-generation thiazolidinedione used mainly in the treatment of non-insulin-dependent… (More)
Is this relevant?
2014
2014
Melatonin has been widely studied as a protective agent against oxidative stress. However, the molecular mechanisms underlying… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1985
1985
The minimal inhibitory concentrations (MICs) of nalidixic acid, pipemidic acid, cinoxacin, oxolinic acid, flumequine, pefloxacin… (More)
Is this relevant?
1985
1985
In a controlled trial of rosoxacin in patients with non-gonococcal urethritis (NGU), 150 mg of the antibiotic given twice daily… (More)
  • table I
Is this relevant?
1984
1984
An open study was designed primarily to evaluate the efficacy of rosoxacin in the treatment of gonorrhoea caused by penicillinase… (More)
  • table I
  • table IV
  • table III
Is this relevant?
1984
1984
Between 3 January and 4 March 1983 we treated 200 male patients diagnosed as having uncomplicated gonococcal urethritis with one… (More)
  • table II
  • table I
  • table III
Is this relevant?
1982
1982
A comparative study of the new antibacterial agent, rosoxacin, a quinoline derivative, with spectinomycin was made in women with… (More)
  • table 11
  • table III
Is this relevant?
1982
1982
A study of the new anti-bacterial agent, rosoxacin, a quinoline derivative was made in male subjects with uncomplicated acute… (More)
Is this relevant?
1981
1981
The in-vitro activity of rosoxacin against 173 isolates of Neisseria gonorrhoeae, including 17 beta-lactamase-producers, was… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1980
1980
The antimicrobial activity of rosoxacin, a new quinoline antibacterial compound, was determined against the causative organisms… (More)
Is this relevant?